Patient Access

As the benefits of psychedelic therapy are more widely recognised, so is the importance of set and setting in mental health treatment. Now emerging technologies from AI-powered soundscapes to immersive, digital experiences are seeking to improve them. While the psychedelic field awaits regulation and destigmatisation, do new technologies promote access and help develop the psychedelic … Continued

  Psychedelics, substances that produce non-ordinary states of consciousness, are currently being heralded as the therapeutic saviours for our long-standing mental health crisis, with preliminary studies showing promising results for psilocybin, MDMA and Ketamine-assisted therapy for depression, PTSD and addiction.  However, whatever way you dress it up, the psychedelic trip and all it entails (insert … Continued

  “It’s putting patients into vulnerable situations through no fault of their own.” I became a medical cannabis patient for my attention deficit hyperactive disorder (ADHD) and Generalised Anxiety Disorder (GAD) during lockdown. During the pandemic, I was separated from my family in Ireland and unable to travel. So, I hadn’t realised how difficult this … Continued

  Psilocybin, the psychoactive ingredient in magic mushrooms, can be effective in treating major depression for up to one year, a new study shows. As scientists try to find a cure for depression, which affects over 280 million people globally, psilocybin is at the center of a resurgence in medical research on psychedelic drugs, with … Continued

  As the revolutionary therapeutic potential of psychedelics resurfaces in popular consciousness, pharmaceutical companies are scrambling for patents over psychedelic compounds and therapies.  The unique characteristics of psychedelics provoke a plethora of ethical implications in intellectual property law and our capitalist society more broadly; namely, that the patenting of psychedelic compounds promotes biopiracy and threatens … Continued

  Ketamine is beginning to be used as a treatment for mental health conditions such as depression and addiction and although research is progressing, societal stigma has been a significant barrier. This has limited access to funding, in turn limiting clinical research and a desire to engage in this area.  Research has shown that public … Continued

  Throughout this week we have been spotlighting the women in the medical cannabis sector. We have had the opportunity to catch up with some of our fantastic old friends, as well as get to know some new and inspiring women, who are true trailblazers in the sector. To conclude this exciting week we got … Continued

For the latest in our series spotlighting women in the medical cannabis industry, we spoke to Monique Ellis, CEO and Co-Founder of CHILAM. During our chat, we spoke about Monique, her journey into the sector, the work she does at CHILAM, and how her background in tech has prepared her for working in this predominantly male … Continued

It has been an incredible week here at Volteface where we have been spotlighting the work of women in the medical cannabis sector. We’ve already heard from Carly Barton and Hannah Deacon about their journeys into the sector, as well as their experiences of this male dominated field. We have had the delight of meeting … Continued